-
Population Pharmacokinetics Model of Thioguanine in Patients with Inflammatory Bowel Disease
Bayoumy, A. B., de Boer, N. K. H., Keizer, R. J. & Derijks, L. J. J., Aug 2025, In: Clinical Pharmacokinetics. 64, 8, p. 1255-1262 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Inflammatory Bowel Disease in a Patient Returning from Colombia: Association with Dipeptidyl Peptidase 4 Inhibitor?
Bayoumy, A. B., Masclee, G. M. C., de Boer, N. K. H., Neefjes-Borst, A. & Stenvers, D. J., 21 Feb 2025, In: Case reports in gastroenterology. 19, 1, p. 89-95 7 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease
Bayoumy, A. B., Derijks, L. J. J. & de Boer, N. K. H., 1 Feb 2025, In: Inflammatory bowel diseases. 31, 2, p. 612-613 2 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications
